Pediatric Infectious Disease

Register      Login

VOLUME 3 , ISSUE 1 ( January-March, 2021 ) > List of Articles

REVIEW ARTICLE

Fungal Infections in Children: A Simplified Approach

Shweta Chitkara, Ravinder Kaur

Keywords : Antifungal agents, Aspergillosis, Candidemia, Invasive fungal infections, Neonatal sepsis, Ringworm, Tinea

Citation Information : Chitkara S, Kaur R. Fungal Infections in Children: A Simplified Approach. Pediatr Inf Dis 2021; 3 (1):26-32.

DOI: 10.5005/jp-journals-10081-1277

License: CC BY-NC 4.0

Published Online: 01-03-2021

Copyright Statement:  Copyright © 2021; Jaypee Brothers Medical Publishers (P) Ltd.


Abstract

Fungal infections in pediatric practice are too common and yet often not discussed. Superficial fungal infections are primarily due to a poor personal hygiene. They are easy to treat provided a prompt diagnosis is made and prolonged topical antifungals are used, occasionally requiring oral antifungals. Systemic fungal infections are assuming great importance because of rampant antibiotic use, increasing intensive care centers and a big subsection of survivors in oncology, primary, and acquired immunodeficient states. The key to a successful management rests on a high index of suspicion in the vulnerable population, laboratory evidence and selecting the appropriate antifungal drug based on the local epidemiology.


PDF Share
  1. Kelly BP. Superficial fungal infections. Pediatr Rev 2012;33(4):e22–e37. DOI: 10.1542/pir.33-4-e22.
  2. Andrews MD, Burns M. Common tinea infections in children. Am Fam Physician 2008;77(10):1415–1420.
  3. Pana ZD, Roilides E, Warris A, et al. Epidemiology of invasive fungal disease in children. J Pediatric Infect Dis Soc 2017;6(Suppl_1):S3–S11. DOI: 10.1093/jpids/pix046.
  4. Warris A. European Paediatric mycology network (EPMyN)*. The European Paediatric Mycology Network (EPMyN): towards a better understanding and management of fungal infections in children. Curr Fungal Infect Rep 2016;10(1):7–9. DOI: 10.1007/s12281-016-0252-7.
  5. Paramythiotou E, Frantzeskaki F, Flevari A, et al. Invasive fungal infections in the ICU: how to approach, how to treat. Molecules 2014;19(1):1085–1119. DOI: 10.3390/molecules19011085.
  6. Jordan I, Balaguer M, López-Castilla JD, et al. Per-species risk factors and predictors of invasive Candida infections in patients admitted to pediatric intensive care units: development of ERICAP scoring systems. Pediatr Infect Dis J 2014;33(8):s187–s193. DOI: 10.1097/INF.0000000000000274.
  7. León C, Ruiz-Santana S, Saavedra P, et al. Usefulness of the “Candida score” for discriminating between Candida colonization and invasive candidiasis in non-neutropenic critically ill patients: a prospective multicenter study. Crit Care Med 2009;37(5):1624–1633. DOI: 10.1097/CCM.0b013e31819daa14.
  8. Raveendran S, Lu Z. CT findings and differential diagnosis in adults with invasive pulmonary aspergillosis. Radiology of Infectious Diseases 2018;5(1):14–25. DOI: 10.1016/j.jrid.2018.01.004.
  9. Sanguinetti M, Posteraro B, Beigelman-Aubry C, et al. Diagnosis and treatment of invasive fungal infections: looking ahead. J Antimicrob Chemother 2019;74(2):s27–s37. DOI: 10.1093/jac/dkz041.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.